What was the decreased risk for women taking estrogen plus progestin for colorectal cancer?
A woman was less likely to develop colorectal cancer if she was taking E+P. For every 10,000 women taking estrogen plus progestin, six fewer women will develop colorectal cancer while taking estrogen plus progestin. While reducing the risk developing the risk of developing colorectal cancer is favorable, the colorectal cancer cases which developed in women taking E+P were more advanced; about 76% had spread to lymph nodes or elsewhere in the body, compared to 49% of women on placebo.
Related Questions
- When did the increased risk of breast cancer become apparent for women taking estrogen plus progestin compared to women taking placebo pills?
- What happens with colorectal cancer risk in women taking estrogen alone (without progestin) or other E+P formulas?
- What was the decreased risk for women taking estrogen plus progestin for colorectal cancer?
